Guest editors Michael Nader and Susan Wood recently published an editorial for their special section in JPET on P.B. Dews and the behavioral determinants of drug action. Read their editorial and check out the collection: https://ow.ly/CsZi50YYWrv #pharmsky 🧪

The deadline of JPET's new special collection, “Multi-Systems Pharmacology and Therapeutic Application of Adipokines and Neuropeptides in Obesity,” is August 31! Interested in publishing in a top pharmacology journal? Learn more and submit your research: https://ow.ly/HGA350YYh1J #pharmsky 🧪

If you want to advance in your career to a leadership position, make sure to sign up for the ASPET Leadership Academy. We prepare biomedical and pharmacological professionals to take part in, and shape the future of, academia and industry. Learn more: https://ow.ly/CmYn50YXCmy #pharmsky 🧪

Join us for the ASPET Awardee Lecture Series, featuring three distinguished scientists presenting on different, exciting areas of science. These lectures are open to both ASPET members and non-members, and free to attend! Learn more and register: https://ow.ly/Ct9F50YSQ2C #pharmsky 🧪

Send in your research for Molecular Pharmacology's special collection on "New Frontiers in GCPR Signaling: Emerging Investigator Highlights." The deadline is August 31. Learn more: https://ow.ly/Sbgt50YYUGn #pharmsky 🧪

Feeling creative? ASPET is seeking your artwork that covers a range of pharmacology. We'll select five images, each of which will be used as the cover for one of ASPET’s journals for 2027! Winning images will also be awarded $250.00. Learn more: https://ow.ly/f19B50YXFKS #pharmsky 🧪

Meet Aiming Yu, PhD, ASPET Councilor-elect and member of the Publications Committee. Dr. Yu has held many roles. Dr. Yu shares his story and advice for young scientists: https://thepharmacologist.org/leadership-profile-apr-2026/

Meet the early-career scientists, Alex White, PhD, Alex Mabou Tagne, PharmD, PhD, and Yimei Wang, who have been highlighted in the April 2026 issue of The Pharmacologist. Learn what drives them and why their research is important to them: https://thepharmacologist.org/on-their-way-apr-2026/

Announcing Clinical Pharmacology, a new section that offers an opportunity for investigators to show their talent in designing and conducting clinical pharmacokinetic/pharmacodynamic studies. Learn more and submit your work: https://ow.ly/btB950YVANv #pharmsky 🧪

The Industry Science Track at ASPET 2026 will include symposia led by experts, discussions, and career development workshops, making this track especially valuable for trainees and early-career scientists looking to move into the private sector: https://ow.ly/nPFz50YQGRu

Read Drug Metabolism and Disposition's recent Editor's Choice, and share it with your colleagues: https://ow.ly/8f5550YUGMe #pharmsky 🧪

Join us for the ASPET Awardee Lecture Series, featuring three distinguished scientists presenting on different, exciting areas of science. These lectures are open to both ASPET members and non-members, and free to attend! Learn more and register: https://ow.ly/y18950YSQ2B #pharmsky 🧪

Researchers at Cancer Research Laboratory are making great strides for the future of prostate cancer management. They demonstrated that Gnetin C could more potently reduce proliferation, survival, angiogenesis, and metastatic potential of prostate cancer cells: https://ow.ly/1g2W50YQGvO

JPET's recent Editor's Choice shows how Traynor and colleagues have produced data supporting the potential of positive allosteric modulators of MOR as effective and safe opioid-sparing agents for pain management: https://jpet.aspetjournals.org/article/S0022-3565(26)00503-3/abstract #pharmsky 🧪

Are you (or someone you know) a grad student, postdoc, or early career investigator who is interested in science policy and advocacy or a potential career in policy? Then the ASPET Washington Fellows Program is for you! 📅 Applications Due: June 30 🔗https://ow.ly/o98r50YOHi4

Winnie Wen, a 4th-year PhD candidate, is the JPET HTA for May 2026. Wen's research focuses on understanding how highly abundant lipid binding proteins inside cells can influence drug exposure: https://doi.org/10.1016/j.jpet.2026.104309

Are you ready to elevate your leadership skills? The ASPET Leadership Academy prepares biomedical and pharmacological professionals to take part in academia and industry leadership. Learn more about this new opportunity: https://ow.ly/OIPf50YQE1X #pharmsky 🧪

Time is running out ⌛ to read DMD's Featured Article: Profiling RNA metabolism to understand tissue and subcellular clearance of therapeutic RNA. This article has been selected as free to read through April! Check it out here: https://ow.ly/sVtN50YRRGt #pharmsky 🧪

Dave Jackson discusses programming highlights at ASPET 2026, including the Keynote speakers, the diverse selection of sessions, the 500+ posters, the GPCR Colloquium, the variety of networking and community-building opportunities, and more: https://ow.ly/jHIC50YQBCp

📢 The deadline for JPET's special collection, "Multi-Systems Pharmacology and Therapeutic Application of Adipokines and Neuropeptides in Obesity," has been extended! Read the description and requirements, and send us your research by August 31! https://ow.ly/wp8o50YRhtU #pharmsky 🧪

Researchers from Emory University have identified negative allosteric modulators for the GluN1/GluN3A receptor. This could enable a better understanding of those receptors in health and disease. Learn more in Molecular Pharmacology's Editor's Choice: https://ow.ly/q0rR50YQHLm #pharmsky 🧪

This is important for our future in medicine.

Randy Hall, PhD, discusses the challenges that many international scientists who want to visit the United States are facing. He also shares how these restrictions can hurt scientists and companies here and abroad. ➡️ Read here: https://thepharmacologist.org/message-from-the-president-apr-2026/

For more than four decades, AMSPC has shaped the teaching, and advancing the scientific bases, of the pharmacological sciences. Dive into this informative history of the association and an in-depth interview with President Nancy Walworth, PhD. 🔗 https://thepharmacologist.org/amspc/

Andersen et al. quantitatively determined the efficiencies of 3 major RNases in various rat tissues and subcellular fractions in metabolizing RNAs, enabling the development of new RNA therapeutics. Learn more: https://ow.ly/Z6xK50YO6Ns #pharmsky 🧪

Biomedical scientists: make sure you attend the 39th Annual Scientific Meeting of ASPET's Great Lakes Chapter on Friday, June 12th. This year's theme is "Advances in GLP-1 Pharmacology: Obesity and Beyond." Discount registration ends May 15: https://ow.ly/nTs350YO5Fp #pharmsky 🧪

⏰ Tomorrow, April 21, is the FINAL day to take advantage of discounted pricing for ASPET 2026 - the pharmacology event of the year! You don’t want to miss the opportunity to save up to $150 on registration fees before prices go up. Register now and save: https://www.aspet.org/aspet2026/registration

Yimei Wang, a 4th-year PhD candidate, is the Drug Metabolism and Disposition HTA for April 2026. Her research utilizes in vivo fermentation with tRNA scaffold and tRNA-fused pre-miRNA carrier technologies to produce novel recombinant miRNA molecule: https://doi.org/10.1016/j.dmd.2026.100292

Announcing the ASPET Leadership Academy! Make sure you're ready for a leadership position with this webinar series, dedicated to preparing health sciences professionals for leadership roles. Learn more and register: https://ow.ly/QrMi50YIg36 #pharmsky 🧪

Are you ready to take an active role in shaping the future of pharmacology and toxicology? Drug Metabolism and Disposition is seeking a new Editor-in-Chief. Learn more about the position and application: https://dmd.aspetjournals.org/news #pharmsky 🧪

Each month, JPET selects a featured article that is free-to-read. This month we're proud to present "Pharmacogenetic influence on bupropion bioactivation and clinical outcomes in major depressive disorder." Read and share this important research: https://ow.ly/Clij50YFK64 #pharmsky 🧪

Traci Czyzyk, PhD, MBA and Marcus Delatte, PhD, highlights how strong mentor-mentee relationships can shape career growth by providing guidance, confidence, and valuable professional connections: https://thepharmacologist.org/industry-insights-mar-2026/

You have until August 31 to submit your work to Molecular Pharmacology's upcoming special collection, which celebrates the world-leading research showcased by attendees of the 5th Transatlantic ECI GPCR Symposium. Learn more: https://ow.ly/CGTm50YGvB9 #pharmsky 🧪

Meet the early-career scientists, Sherouk Tawfik and Sadikshya Aryal who have been highlighted in the March 2026 issue of The Pharmacologist. Learn what drives them and why their research is important to them. ➡️ Read "On Their Way..." here: https://thepharmacologist.org/on-their-way-mar-2026/

Interested in publishing or reading research articles pertinent to Clinical Pharmacology? This editorial, from JPET's editor-in-chief Beverley Greenwood-Van Meerveld and associate editor Giorgio Minotti, explains the journal's newest section: https://ow.ly/LYbS50YF0Mq #pharmsky 🧪

Are you considering a career change, or have you or your colleagues been affected by recent transformations at the federal, academic, or industry level? Learn about different career trajectories, meet potential mentors and mentees, and more at ASPET 2026! 🔗 https://ow.ly/aOwG50YEtwT

Andersen et al. quantitatively determined the efficiencies of 3 major RNases in various rat tissues and subcellular fractions in metabolizing RNAs, enabling the development of new RNA therapeutics. Read DMD's Editor's Choice to learn more: https://ow.ly/hGkp50YEFUj #pharmsky 🧪

Researchers at the UT-San Antonio Health Science Center are developing a new mu opioid receptor antagonist that shows promise as a next‑generation overdose antidote. Read about their research in this issue's Editor's Choice of JPET: https://ow.ly/q3fa50YAUrv 🧪#pharmsky

Alex White, PhD, is the Molecular Pharmacology HTA for April 2026. His research focuses on understanding the signaling mechanisms of GPCR that underlie their biology with the hopes that these insights can be exploited to develop novel therapies: https://doi.org/10.1016/j.molpha.2026.100111

Inspired by ASPET President Randy Hall’s article on artificial intelligence and its potential impact on pharmacology, Executive Officer Dave Jackson discusses how ASPET is - and has been - providing content focused on AI for its members: https://thepharmacologist.org/note-from-daves-desk-mar-2026/

Researchers from Emory University have identified negative allosteric modulators for the GluN1/GluN3A receptor. This could enable a better understanding of those receptors in health and disease. Learn more in Molecular Pharmacology's Editor's Choice: https://ow.ly/zonV50YAUXy #pharmsky 🧪

Scientists come to ASPET's annual meeting to hear from distinguished keynote speakers and learn about recent breakthroughs. But science happens through connection, and ASPET 2026 offers a number of unique ways for you to connect with your colleagues! https://ow.ly/HU6s50YAGH3 🧪

Interested in learning about the development of a drug that could help patients recover after a stroke or TBI? Read the Editor's Choice in the recent issue of The Journal of Pharmacology and Experimental Therapeutics: https://jpet.aspetjournals.org/article/S0022-3565(26)00025-X/abstract 🧪#pharmsky

Randy Hall, PhD, discusses how AI could transform biomedical research, not as a replacement for scientists but as a powerful collaborator. In the next few decades, researchers who master this partnership may ultimately define the next era of biomedical discovery: https://ow.ly/rksH50YAGfJ

Dive into the pioneering work of Dr. William Coley, whose controversial experiments using bacterial toxins to trigger immune responses led to unexpected cancer remissions, earning him recognition as the “Father of Cancer Immunotherapy.” 🔗https://thepharmacologist.org/william-coley/

ICYMI: Teresa K. Woodruff, PhD, an internationally recognized reproductive biologist, will speak at ASPET 2026! Hear the story of how her research efforts in ovarian follicle culture led her to think about potential applications of the technology. 🧪 https://www.aspet.org/ASPET2026/Registration

JPET has launched a new research article section: Clinical Pharmacology! This new section will let investigators show their talent in designing and conducting clinical pharmacokinetic/pharmacodynamic studies. Learn more about how you can contribute your work: https://ow.ly/hTYt50YykYE #pharmsky 🧪

The deadline has been extended to August 31 for Molecular Pharmacology's upcoming special collection, which celebrates the world-leading research showcased by attendees of the 5th Transatlantic ECI GPCR Symposium. Learn more: https://ow.ly/5sy350Ywmev 🧪#pharmsky

There’s still time to register for the remaining Spring Division Town Halls! Learn about the divisions' latest activities and how to get involved, get a sneak peek of ASPET 2026 presentations, and network with colleagues and peers. 🔗 Register: https://ow.ly/6sLq50Ywh53

Sadikshya Aryal, a 5th-year PhD candidate, is the Molecular Pharmacology Highlighted Trainee Author for March 2026. Her research focuses on understanding how a key signaling enzyme in the nervous system, called AC1, is regulated inside cells. 🔗 https://doi.org/10.1016/j.molpha.2026.100101